Nexia Biotechnologies Inc Company Profile

02:12 EDT 5th May 2015 | BioPortfolio

Until recently Nexia developed and manufactured complex recombinant proteins in the milk of transgenic goats for medical and industrial applications. The Company's two lead programs were Protexia and BioSteelR.On March 7, 2005, Nexia's, shareholders approved the sale of substantially all its operations and assets related to ProtexiaR to PharmAthene (www.pharmathene.com), a privately held biotechnology company focused on the development of biodefense therapeutics, based in Annapolis, Maryland, USA.

Location

P.O. BOX 187Branch Jean-Talon
Montreal
Quebec
H1S 2Z2
Canada

Contact

Phone: 514.586.3942
Fax: 514.371.7880
Email: investors@nexiabiotech.com


News Articles [118 Associated News Articles listed on BioPortfolio]

Nexia, Inst. of Plant Genetics in transgenics deal

Nexia Biotechnologies (complex recombinant proteins) will collaborate with the Institute of Plant Genetics & Crop Plant Research (IPG) in developing a method for manufacturing spider silk proteins in ...

ExpreS2ion Biotechnologies – production in Drosophila S2 cells

ExpreS2ion Biotechnologies is a world leading contract research organization (CRO) for the production in Drosophila Schneider-2 (S2) cells using its proprietary and complete S2 recombinant protein tec...

Adaptive Biotechnologies to purchase immunosequencing firm

Adaptive Biotechnologies said it secured $94 million in private equity funding and used the money to acquire Sequenta, an imm -More- 

Minerva Biotechnologies Corp.

Minerva Biotechnologies Corp. is engaged in the development of novel biosensors.

Stellar Biotechnologies Reports Year-End 2014 Financial Results / Company to Hold Conference Call at 1:30 p.m. ET Today

PORT HUENEME, CA -- (Marketwired) -- 11/13/14 -- Stellar Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF) (TSX VENTURE: KLH), the leader in sustainable manufacture of Keyhole Limp...

Lion Biotechnologies seeks FDA's approval for trial of melanoma candidate

Lion Biotechnologies has submitted an application to the FDA for approval to initiate a midstage trial of its autologous T ce -More- 

Matinas BioPharma acquires Aquarius BioTechnologies

Matinas BioPharma Holdings has acquired all of the outstanding stock of Aquarius BioTechnologies, an innovative bio-delivery drug discovery company with a novel and proprietary lipid-crystal nano-part...

FOPO nets $111mm for Avalanche Biotechnologies

In a follow-on public offering, the first since the company went public last year, Avalanche Biotechnologies Inc. (Ocular BioFactory platform to generate gene therapies for AMD and other eye diseases)...

Drugs and Medications [0 Results]

None

PubMed Articles [13 Associated PubMed Articles listed on BioPortfolio]

Camelid Genetics and Reproductive Biotechnologies.

Federalism and bioethics.

Abstract The absence of comprehensive federal oversight of human biotechnologies in the United States continues to stimulate academic discourse on the relative merits of European-style regulatory agen...

Cyborgs, biotechnologies, and informatics in health care - new paradigms in nursing sciences.

Nursing Sciences are at a moment of paradigmatic transition. The aim of this paper is to reflect on the new epistemological paradigms of nursing science from a critical approach. In this paper, we ide...

Investigation of iron-containing products from natural and laboratory cultivated Sphaerotilus-Leptothrix bacteria.

Bacterial biomass collected from sheath-forming bacteria of the genera Sphaerotilus and Leptothrix was collected from a high-mountain natural stream water source. The elemental constitution and oxide ...

Connectomics: comprehensive approaches for whole-brain mapping.

The aim of connectomics analysis is to understand whole-brain neural connections. This is accomplished using new biotechnologies. Here, we provide an overview of the recent progress in connectomics an...

Clinical Trials [0 Results]

None

Companies [100 Associated Companies listed on BioPortfolio]

Nexia Biotechnologies Incorporated

Nexia Biotechnologies is one of the world's largest producers of authentic recombinant spider silk, and a leading North American animal transgenic company. Nexia manufactures biomaterials and therapeu...

Nexia Biotechnologies Inc

Until recently Nexia developed and manufactured complex recombinant proteins in the milk of transgenic goats for medical and industrial applications. The Company's two lead programs were Protexia and ...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Nexia Holdings, Inc.

Genemed Biotechnologies Incorporated

Genemed Biotechnologies Inc. provides high quality contract manufacturing services for a wide variety of research and diagnostic products including native or recombinant proteins and nucleotides

More Information about "Nexia Biotechnologies Inc" on BioPortfolio

We have published hundreds of Nexia Biotechnologies Inc news stories on BioPortfolio along with dozens of Nexia Biotechnologies Inc Clinical Trials and PubMed Articles about Nexia Biotechnologies Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Nexia Biotechnologies Inc Companies in our database. You can also find out about relevant Nexia Biotechnologies Inc Drugs and Medications on this site too.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Biotechnology - Biotech
Latest News Clinical Trials Research Drugs Reports Corporate
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record